Meet our Scientists

Get to know the incredible individuals behind the work we fund. Our researchers are based across the UK at the Ovarian Cancer Action Research Centre, University of Oxford and beyond.

These dedicated scientists are working tirelessly to change the future for women with ovarian cancer. We fund their projects because we believe these areas will accelerate change and improve the survival rates of women with ovarian cancer.

Professor Iain McNeish

Professor Iain McNeish is the Director of the Ovarian Cancer Action Research, Centre incorporating The Vivienne Wohl Unit at Imperial College.
Professor Ahmed Ahmed

We fund the work of Professor Ahmed Ahmed at the Weatherall Institute of Molecular Medicine at the University of Oxford.
Dr Jonathan Krell

Dr Jon Krell is a Senior Clinical Lecturer in Medical Oncology at Imperial College London and has a particular interest in cancer genetics.
Professor Graham Cook

My research group is interested in how the immune system recognises cancer and in particular, how we might manipulate the immune system to attack cancer, a strategy known as immunotherapy.
Dr Fiona Errington-Mais

Ovarian Cancer Action currently fund an immunotherapy-based project entitled “Next generation oncolytic viruses for the immunotherapy of ovarian cancer”.
Laura Tookman

am excited to be working on the British Translational Research Ovarian Cancer Collaborative (BriTROC 2) project.
Nina Wietek

Nina is a clinical research fellow and DPhil (PhD) student based in at the Weatherall Institute of Molecular Medicine at the University of Oxford.
Luyao Wang

Luyao Wang is a Postdoctoral Research Assistant in Translational Cancer Immunology at the University of Oxford. Here she tells us about her work on ovarian cancer treatment using adoptive T cell therapy.
Dr Mark P. Lythgoe

Dr Mark P. Lythgoe is an academic clinical fellow at our Ovarian Cancer Action Research Centre, providing clinical care into multiple projects and seeking to understand how genetics can affect the development of ovarian cancer - and therefore the treatment of genetic cancers.